-
Mashup Score: 18FDA Approves Ankiva Plus Bacillus Calmette-Guérin For Non-Muscle Invasive Bladder Cancer - 28 day(s) ago
The approval was based on the QUILT-3.032 study, which included 77 adults with carcinoma in situ with or without papillary tumors after a transurethral resection.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 36FDA Approves Ankiva Plus Bacillus Calmette-Guérin For Non-Muscle Invasive Bladder Cancer - 28 day(s) ago
The approval was based on the QUILT-3.032 study, which included 77 adults with carcinoma in situ with or without papillary tumors after a transurethral resection.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
FDA approves Ankiva Plus Bacillus Calmette-Guérin (BCG) for BCG-unresponsive NMIBC #BladderCancer #pharmacy Read More: https://t.co/EseYkNQrek